Center-Authored Papers

Filters: Author is Malkki, Mari  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson H-W, Farin FM, Carter JJ, Galloway DA, Daling JR et al..  2008.  Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(7):1790-9. Abstract
Bodelon C, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.  2013.  Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.. International journal of molecular epidemiology and genetics. 4(4):218-27. Abstract
Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T.  2013.  Comparison of statistics in association tests of genetic markers for survival outcomes.. Statistics in medicine. Abstract
D
Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf EW, Hsu KC.  2010.  Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.. Blood. 115(15):3162-5. Abstract
E
Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon J-D, Dubois V, Horowitz MM, Madrigal AJ, Morishima Y et al..  2012.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.. The lancet oncology. 13(4):366-374. Abstract
G
Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.  2012.  Genetic variation in CD83 and risks of cervical and vulvar cancers: A population-based case-control study.. Gynecologic oncology. 124(3):525-528. Abstract
Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, McKnight B, Malone KE.  2011.  Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.. Breast cancer research and treatment. 129(3):887-899. Abstract
Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.  2013.  Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: A population-based case-control study.. International journal of cancer. Journal international du cancer. Abstract
Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.  2013.  Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.. BMC cancer. 13:219. Abstract
Malkki M, Petersdorf EW.  2012.  Genotyping of single nucleotide polymorphisms by 5' nuclease allelic discrimination.. Methods in molecular biology (Clifton, N.J.). 882:173-82. Abstract
H
Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P.  2015.  High HLA-DP Expression and Graft-versus-Host Disease.. The New England journal of medicine. 373(7):599-609. Abstract
Woolfrey AE, Lee SJ, Gooley TA, Malkki M, Martin PJ, Pagel JM, Hansen JA, Petersdorf EW.  2010.  HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1382-7. Abstract
Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T et al..  2014.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.. Blood. 124(26):3996-4003. Abstract
Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B et al..  2012.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. The New England journal of medicine. 367(9):805-16. Abstract
I
Tseng L-H, Storer BE, Petersdorf EW, Lin M-T, Chien JW, Grogan BM, Malkki M, Chen P-J, Zhao LP, Martin PJ et al..  2009.  IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.. Transplantation. 87(5):704-10. Abstract
K
Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec J-B, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H et al..  2017.  KIR3DL1/ HL A-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016707059. Abstract
M
Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T.  2013.  Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.. Blood. Abstract
Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T.  2012.  MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation.. Science translational medicine. 4(144):144ra101. Abstract
N
Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.  2013.  Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: A hybrid case-parent triad and case-control study.. International journal of cancer. Journal international du cancer. 133(1):201-13. Abstract
P
Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.  2015.  A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.. Gynecologic oncology. 139(1):90-6. Abstract
R
Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, Madeleine MM.  2011.  Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(1):199-207. Abstract
S
Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy J-M, Senitzer D et al..  2013.  Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1197-203. Abstract
W
Baron F, Petersdorf EW, Gooley TA, Sandmaier BM, Malkki M, Chauncey TR, Maloney DG, Storb R.  2009.  What is the role for donor natural killer cells after nonmyeloablative conditioning? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(5):580-8. Abstract